|
CytRx Corporation - Company Profile Snapshot
| Company Profile: |
CytRx Corporation |
| Ticker: |
CYTR |
| Exchanges: |
NAS |
| 2008 Sales: |
6,266,200 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
UNITED STATES |
| Employees: |
35 |
Business Description
CytRx Corporation. The Group's principal activity is developing and commercializing pharmaceutical products. It is involved in the development of novel small molecules based on molecular 'chaperone' co-induction technology, with broad therapeutic applications in neurology, diabetes and cardiology. Products are used for treatment of obesity, type 2 diabetes and human cytomegalovirus.
|
Not the Report you are looking for? Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address - Earnings/Dividends - Employees - Exchanges Listed - Financial Ratio Analysis |
- Recent Stock Performance - Sales (recent year) - Senior Officers - Shareholder Information - Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|